References
BENEDUM, U.M., LAMOUROUX, A., KONECKI, D.S., ROSA, P., HILLE, A., BAEUERLE, P.A., FRANCK, R., LOTTSPEICH, F., MALLET, J., and HUTTNER, WB. (1987). The primary structure of human secretogranin I (chromogranin B): comparison with chromogranin A reveals homologous terminal domains and a large intervening variable region. EMBO J. 6:1203–121.
COOKE, N.E., COIT, D., WEINER, R.I., BAXTER, J.D., and MARTIAL, J.A. (1982). Structure of cloned DNA complementary to rat prolactin messenger RNA. J. BIOL. CHEM. 255:6502–6506.
CURRAN, T. and FRANZA, R. (1988). Fos and Jun: the API connection. CELL. 55:395–397.
FRAWLEY, L.S. and BOOCKFOR, F.R. (1991). Mammosomatotropes: presence and functions in normal and neoplastic tissue. ENDOCR. REV. 12:337–355.
GERSHENGORN, M.C. (1989). “Role of inositol lipid lecond messengers in regulation of secretion: studies of Thyrotropin-releasing Hormone action in pituitary cells.” In: Secretion and its control, pp. 1–15, The Rockefeller University Press, New York.
GOURDJI, D. (1985). Multihormonal regulation of the pituitary gland: bunding and secretory responses to hypothalamic neuropeptides in rat GH pituitary strains in culture. NEUROCHEM. INT. 7:979–994.
GOURDJI, D., BUISSON, N., WEISMAN, A.S. and LAVERRIERE, J.N. (1990). A. Tixier-Vidal c.fos proto-oncogene expression and prolactin release share common neuroendocrine control. Neuroendocrinology, 2nd International Congress of Neuroendocrinology, Bordeaux France, June 24–29, Abstract, S 15.3, p34.
GOURDI, D., LAVERRIERE, J.N., PASSEGUE, E. BUISSON, N., and RICHARD, J.L. (1991). Régulations multigéniques et activités sécrétoires dans des cellules mammosomatotropes. XXème Congrès de la Société de Neuroendocrinologie Experimentale. Ann. Endocrinol. 52:11N.
GOURDJI, D., LAVERRIERE, J.N., WEISMAN, A.S., BUISSON, N., and TIXIER-VIDAL, A. (1989). c.fos mRNA and PRL release are regulated in parallel in GH3B6 rat pituitary tumor cells. 71st Annual Meeting of the Endocrine Society, 1989, 827.
GOURDJI, D., LAVERRIERE, J.N., WEISMAN, A.S., BUISSON, N., and TIXIER-VIDAL, A. (1988). Coordinate expression of genes in relation with prolactin secretion.” In: Prolactin gene family and its receptors. Molecular biology to clinical problems (K. Hoshino, ed), pp. 227–235, Elsevier Science Publishers, Amsterdam.
GOURDJI, D., TOUGARD, C., and TIXIER-VIDAL, A. (1982). “Clonal prolactin strains as a tool in neuroendocrinology.” In: Frontiers in Neuroendocrinology, (W.F. Ganong and L. Martini, eds., Raven Press), 7, pp. 317–357, New York.
GUTMAN, A. and WASYLYK, B. (1991). Nuclear targets for transcription regulation by oncogenes. TIG vol 7, 2:49–54.
INGRAHAM, H.A., ALBERT, V.R., CHEN, R., CRENSHAW,III, B., ELSHOLTZ, H.P., HE, X., KAPILOFF, M.S., MANGALAM, H.J., SWANSON, L.W., TREACY, M.N., and ROSENFELD, M.G. (1990). A family of POU-domain and pit-1 tissue-specific transcription factors in pituitary and neuroendocrine development. Annu. Rev. Physiol. 52:773–791.
HE, X. and ROSENFELD, M.G. (1991). Mechanism of complex transcriptional regulation: implication for brain development. Neuron. 7:183–196.
LAMBERTS, S.W.J. and MCLEOD, M. (1990). Regulation of prolactin secretion at the level of the lactotroph. Physiol. Rev. 70:279–318.
LAVERRIERE, J.N., MORIN, A., TIXIER-VIDAL, A., TRUONG, A.T., GOURDJI, D., and MARTIAL, J.A. (1983). Inverse control of prolactin and growth hormone gene expression: effect of thyroliberin on transcription and RNA stabilization. EMBO J. 2:1493–1499.
LAVERRIERE, J.N., RICHARD, J.L., BUISSON, N.B., MARTIAL, J.A., TIXIER-VIDAL, A., and GOURDJI, D. (1989). Thyroliberin and dihydropyridines modulate prolactin gene expression through interacting pathways in GH3 cells. Neuroendocrinology. 50:693–701.
LAVERRIERE, J.N., RICHARD, J.L., MORIN, A., BUISSON, N.B., TIXIER-VIDAL, A., HUTTNER, W., and GOURDJI, D. (1991). Secretogranin I (chromogranin B) mRNA accumulation is hormonally regulated in GH3B6 rat pituitary tumor cells. Mol. Cel. Endocr. 80:41–51.
LAVERRIERE, J.N., TIXIER-VIDAL, A., BUISSON, N.B., MORIN, A., MARTIAL, J.A., and GOURDJI, D. (1988). Preferential roleof calcium in the regulation of prolactin gene transcription by thyrotropin-releasing hormone in GH3 pituitary cells. Endocrinology. 122:333–340.
MANIATIS, T., FRITSCH, E.F., and SAMBROOK, J. (1982). Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
MELLON, P.L., WINDLE, J.J., WEINER, R.I. (1991). Immortalization of neuroendocrine cells by targeted oncogenesis. Rec. Prog. Horm. Res. 47:69–96.
MORIN, A., LOUETTE, J., VOZ, M.L.J., TIXIER-VIDAL, A., BELAYEW, A., and MARTIAL, J.A. (1990). Triiodothyronine inhibits transcription from the human growth hormone promoter. Mol. Cel. Endocr. 71:261–267.
PEERS, B., VOZ, M.L., MONGET, P., MATHY-HARTERT, M., BERWAER, M., BELAYEW, A., and MARTIAL, J.A. (1990). Regulatory elements controlling pituitary-specific expression of the human prolactin gene. Mol. Cell. Biol. 10:4690–4700.
POLKOWSKA, J., BERAULT, A., HURBAIN-KOSMATH, I., JOLLY, G., and JUTISZ, M. (1991). Bihormonal producing gonadotropins and prolactin in a rat pituitary cell line (RC-4B/C). Neuroendocrinology. 54: 263–73.
RANSONE, L.J. and VERMA, I.M. (1990). Nuclear proto-oncogenes fos and jun. Annu. Rev. Cell Biol. 539–573.
RICHARD, J.L., LAVERRIERE, J.N., BUISSON, N., TIXIER-VIDAL, A., and GOURDJI, D. (1991). “Kinetics of TRH and 1,25 dihydroxyvitamin D3 (1,25.D3) interaction on the expression of PRL and GH genes in GH3B6 pituitary cells.” In: Vitamin D: gene regulation, structure function analysis annd clinical application; Proceedings of the Eight Workshop on vitamin D (Paris). (A.W. Norman, R. Bouillon, M. Thomasset, eds.) pp 28–30, Walter de Gruyter, Berlin.
SEEBURG, P.H., SHINE, J.A., BAXTER, J.D., and GOODMAN, H.M. (1987). Nucleotide Sequence and amplification in bacteria of structural gene for rat growth hormone. Nature. 270:486–488.
STRAUB, R.E., FRECH, G.C., JOHO,R.H., and GERSHENGORN, M.C. (1990). Expression cloning of a cDNA encoding the mouse pituitary thyrotropin-releasing hormon receptor. Proc. Natl. Acad. Sci. USA. 87:9414–9518.
TASHJIAN JR, A.H. (1979). Clonal strains of ormone producing pituitary cells. In: Methods In Enzymology (W.B. Jacoby, I.H. Pastan, eds.) vol 58, pp. 527–535. Academic Press, New York.
TIXIER-VIDAL, A. and GOURDJI, D. (1981). Mechanism of action of synthethc hypothalamic peptides on anterior pituitary cells. Physiol. Rev. 61:974–1011.
TOUGARD, C. and TIXIER-VIDAL, A. (1988). Lactotropes and gonadotropes. In: The Physiology of Reproduction (E. Knobil and J. Neil, eds.), pp. 1305–1333. Raven Press, New York.
WARK, J.D. and TASHJIAN, A.H. (1983). Regulation of Prolactin mRNA by 1,25-Dihydroxyvitamin D3 in GH4.C1 Cells. J. B. Chem. 258:12118–12121.
WEISMAN, A.S., TIXIER-VIDAL, A., and GOURDJI, D. (1987). Thyrotropin-releasing hormone increases the levels of c-Fos and beta-actin mRNA in GH3B6 pituitary tumor cells. In: Vitro Cellular and Developmental Biology. 23: 585–590.
WEISMAN, A.S., TIXIER-VIDAL, A., and GOURDJI, D. (1988). “c-fos and actin gene expression is regulated by thyrotropin releasing hormone and serum in GH3/B6 pituitary tumor cells.” In: Progress in Cancer Research and Theraphy, (F. Bresciani, R.J.B. King, M.E. Lippman, and J.P. Raynaud, eds.) vol. 35: Hormone and Cancer 3, Raven Press, LTD, New York.
WIEDENMANN, B. and HUTTNER, W.B. (1989). Synaptophysin and Chromagranins/Secretogranins-widespread constituents of distinct types of neuroendocrine vesicles and new tolls in tumor diagnosis. Virchows Archiv B Cell Pathol. 58:95–121.
YAN, G., PAN, W.T., and BANCROFT, C. (1991). Thyrotropin-releasing hormone action on the prolactin promoter is mediated by the POU protein PIT-1. Molecular Endocrinology. 5:535–541.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gourjii, D., Laverriere, JN., Passegué, E. et al. Hypophyseal cells model systems: the “GH” rat tumor-derived cell lines as a tool for the study of gene expression. Cell Biol Toxicol 8, 29–38 (1992). https://doi.org/10.1007/BF00130508
Issue Date:
DOI: https://doi.org/10.1007/BF00130508